The mRNA expression at baseline of β-catenin, the key effector of WNT signaling, was comparable in fibroblasts from individuals with and without COPD, whereas the expression of the intracellular WNT signaling protein DVL3 was significantly higher in individuals with COPD stage II (figure 2G). This evidence concerns the gene DVL3 and chronic obstructive pulmonary disease.